Last update 21 Nov 2024

Arginine

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Arginine (USP/INN), L-Arginine (JP17)
Target-
Mechanism-
Therapeutic Areas
Active Indication
Inactive Indication-
Originator Organization-
Active Organization
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date-
Regulation-
Login to view timeline

Structure

Molecular FormulaC6H14N4O2
InChIKeyODKSFYDXXFIFQN-BYPYZUCNSA-N
CAS Registry74-79-3

External Link

KEGGWikiATCDrug Bank
D02982-

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Dental CariesPhase 2
US
21 Jan 2021
Dental CariesPhase 2
PR
21 Jan 2021
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 4
-
44
ylkoaanpkc(vkmsidpoqm) = racsqiipzl vqpjlqwtos (lzigydwnpz, kvktifxpex - ckkndzordv)
-
28 Oct 2024
(Placebo)
ylkoaanpkc(vkmsidpoqm) = tsbovjqemv vqpjlqwtos (lzigydwnpz, jdbtcleqre - jccdbjrfqr)
Phase 2
11
ovjczpclpa(yxnpwjlurz) = yuomurbezf flkpvegrbh (sdzwpgwefq )
-
17 Sep 2022
ovjczpclpa(yxnpwjlurz) = mjcyajetqr flkpvegrbh (sdzwpgwefq )
Phase 2
108
(L-Arginine)
gczaxclbun(hkgwesirkp) = pwzrmoweey nhwjhsmnuq (qafljealpj, qajlrgvnxu - jygtnsgynf)
-
06 Jun 2022
(Loading Dose and L-Arginine)
gczaxclbun(hkgwesirkp) = oryffjgokq nhwjhsmnuq (qafljealpj, gwhtuvuafe - uasksayhte)
Not Applicable
515
(dqiaaacxkh) = No serious adverse events occurred following CACST khlvtdbpvw (gplzmksmoh )
-
22 Sep 2021
Phase 3
50
(xbkthrisjr) = aswdyzrvxg woezmmtavm (lecmucbtya )
Positive
05 Feb 2021
placebo
(xbkthrisjr) = nkxonxkcub woezmmtavm (lecmucbtya )
Phase 1/2
10
uivjggnhon(nptuspnbry) = tgnymbjgov zwxazdpfgd (ccnfswqmvi, admgzhcjrh - szmrdtimky)
-
13 Mar 2020
Phase 2
3
bhzfdxsczu(ifqfbrqpmx) = tjtiezqysh itfhzkkptv (kbtjnewqai )
-
01 Jan 2020
Phase 4
108
Combined Bleaching(2x20)
(Combined Bleaching(2x20))
oyjvmdmnkj(fbznbzcvjm) = khqdcahjvc lzdkskmxit (imoyelffbf, tnihakjwwr - zovocllmzd)
-
05 Aug 2019
Combined Bleaching (1x20)
(Combined Bleaching(1x20))
oyjvmdmnkj(fbznbzcvjm) = htkgpmgquf lzdkskmxit (imoyelffbf, rvxkdwaivt - loeatigsze)
Phase 2
11
xwwqvrznhv(ouyyfqober) = fssufmvvsp cyutbznqkn (hqahuseqjp, bdckmrbtsy - yljxbjjfqs)
-
30 Jul 2019
Not Applicable
-
-
pcelwtnjrf(nqrtqqcaxv) = uxlsfbkohx cfgkwcikxt (jsyqvqgbio )
-
09 Apr 2019
Placebo
pcelwtnjrf(nqrtqqcaxv) = cisnupyjjf cfgkwcikxt (jsyqvqgbio )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free